BDMAI’s e-marketing portal to promote Indian pharma products and services

Mumbai:  With the launch of the Bulk Drug Manufacturers Association of India (BDMAI)’s e-marketing portal, Indian pharma companies can now promote exclusively Indian APIs, intermediates, pellets, impurities, contract development and manufacturing organization (CDMO)/contract research and manufacturing services (CRAM) services in domestic and global markets, according to industry experts.

Designed as a one-stop digital marketplace, this platform aims to strengthen industry visibility, enhance connectivity, and support the global outreach of Indian bulk drug manufacturers.

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has also urged its member companies to register as BUYER, start search and send enquiries for selected products/manufacturers. The portal offers exclusive no cost to the buyers of APIs.

“It also has a Vendor Management facility which can help in creating a comprehensive and integrated ecosystem for the industry as most of our members are into manufacturing of finished formulations, this portal www.bdmaiem.inhelps in souring of APIs,” informs Pharmexcil director general (DG) K. Raja Bhanu.

The portal allows users to search by product name, company name, CAS number, or HS code, making it simple and efficient to find specific products or manufacturers. It also features an integrated enquiry system, allowing users to send direct enquiries to selected companies through the app itself.

BDMAI brings together the leading manufacturers of APIs, intermediates, pallets, impurities, CDMOs and other related service providers from across the country. Established in 1991 with the aim of promoting the growth, competitiveness, and global standing of India’s bulk drug industry, the Association serves as a unified platform for collaboration, representation, and advancement. It works closely with Central and state governments, regulatory authorities, and industry stakeholders to address common challenges and advocate for policies that strengthen the bulk drug manufacturing ecosystem.

Beyond policy advocacy, the Association actively engages in knowledge sharing, technical seminars, training programs, and industry–academia collaborations to support continuous improvement in quality, compliance, innovation, and sustainability.

Related Posts

Government takes steps to strengthen primary healthcare services

The Union minister of state for health and family welfare, Prataprao Jadhav stated that the government has taken steps to strengthen primary healthcare services in the country. The ministry of…

Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

NEW DELHI: In a major victory for India’s national security and anti-narcotics apparatus, the Central Bureau of Narcotics (CBN), operating under the Department of Revenue, Ministry of Finance, has dismantled…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Government takes steps to strengthen primary healthcare services

Government takes steps to strengthen primary healthcare services

Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide

National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide

Star Bio Pharma Global strengthens its position in the global nutraceutical supply Chain

Star Bio Pharma Global strengthens its position in the global nutraceutical supply Chain

Chemists demand fair competition in pharma market amid online sales concerns

Chemists demand fair competition in pharma market amid online sales concerns

DCA busts unlicensed shop, seizes meds worth Rs 18000

DCA busts unlicensed shop, seizes meds worth Rs 18000